Revista de Senologia y Patologia Mamaria最新文献_第10页

¿Se puede realizar la radioterapia intraoperatoria de forma asistencial en el tratamiento del cáncer de mama en estadios iniciales? 手术中放疗是否有助于早期乳腺癌的治疗?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100500

Javier Sanz-Latiesas , Reyes Ibáñez-Carreras , Arantxa Eraso-Urién , Manuel Algara-López

{"title":"¿Se puede realizar la radioterapia intraoperatoria de forma asistencial en el tratamiento del cáncer de mama en estadios iniciales?","authors":"Javier Sanz-Latiesas , Reyes Ibáñez-Carreras , Arantxa Eraso-Urién , Manuel Algara-López","doi":"10.1016/j.senol.2023.100500","DOIUrl":"10.1016/j.senol.2023.100500","url":null,"abstract":"<div><p>After conservative surgery in breast cancer adjuvant radiation therapy is indicated, such treatment can be performed as partial irradiation in well-selected cases and without risk factors for local relapse following the guidelines of international consensus. Partial irradiation is performed by several techniques such as interstitial brachytherapy, external radiation therapy, and also through intraoperative radiation therapy techniques at the same surgical act due to mobile electron accelerators or low-energy photons units. This allows local treatment to be performed in a single day, increasing the surgical time, but with advantages in terms of the tumor bed localization accuracy, immediacy of irradiation and greater patient satisfaction. There is extensive experience in the use of this technique with results comparable to other ways of partial irradiation in terms of local control, minimal side effects, good cosmetic results and even better no cancer related survival. This article reviews the evidence in the use of intraoperative radiation therapy in early-stage breast cancer derived from the main trials comparing it to whole breast irradiation, to confirm that it is already available for standard of care practice in patients who are candidates for partial irradiation.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100500"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44333073","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

¿Cuál es el fraccionamiento estándar en la irradiación del cáncer de mama? 乳腺癌的标准照射分数是多少?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100511

Fátima Ginés Santiago , María Jesús García-Anaya , María del Carmen Moreno-Manzanaro Moreno , Ángel Calvo-Tudela , Fabiola Romero-Ruperto , Isabel García-Ríos

{"title":"¿Cuál es el fraccionamiento estándar en la irradiación del cáncer de mama?","authors":"Fátima Ginés Santiago , María Jesús García-Anaya , María del Carmen Moreno-Manzanaro Moreno , Ángel Calvo-Tudela , Fabiola Romero-Ruperto , Isabel García-Ríos","doi":"10.1016/j.senol.2023.100511","DOIUrl":"10.1016/j.senol.2023.100511","url":null,"abstract":"<div><p>Radiotherapy (RT) after breast-conserving surgery for breast cancer (BC) has been shown to reduce local recurrence rates and mortality. The conventional treatment of postoperative radiotherapy was 50 to 50.4 Gy, administered in 25 to 28 fractions over a period of 5 to 6 weeks. In the last 20 years, there is clinical evidence to consider hypofractionated treatment regimens safe and effective. Moderate hypofractionation, administered over 3 weeks, can be considered the standard of care after conservative surgery or mastectomy, as well as in irradiation of lymph node areas, with similar results regarding local control and survival and with effects on acute and chronic normal tissue. , similar or smaller. Ultrahypofractionated treatment, administered in 5 sessions, for 1 or 5 weeks, is a safe and effective treatment after conservative surgery and mastectomy without reconstruction. Early results have been reported that ultrahypofractionated treatment in 1 week is safe when lymph node areas are irradiated.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100511"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43554146","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Introducción al machine learning en Senología 机器学习导论

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100503

Eduardo Alcobilla Ferrara

引用次数: 0

¿Se puede rescatar con irradiación la paciente con cáncer de mama oligometástasica? 少代谢性乳腺癌患者能否通过放射治疗获救？

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100501

Arantxa Eraso , Raquel Ciervide , Reyes Ibañez

{"title":"¿Se puede rescatar con irradiación la paciente con cáncer de mama oligometástasica?","authors":"Arantxa Eraso , Raquel Ciervide , Reyes Ibañez","doi":"10.1016/j.senol.2023.100501","DOIUrl":"10.1016/j.senol.2023.100501","url":null,"abstract":"<div><p>Improvements in our understanding of the biology of cancer have led to significant advancements in the diagnóstico and treatment of metastatic breast cancer. However, it is generally considered incurable. Currently, the European and American Societies for Radiation Therapy define oligometastatic disease as the presence of 1–5 treatable metastatic lesions. Although oligometastatic breast cancer has a more favorable prognosis than more advanced stages, there remains a significant challenge in identifying which patients would benefit most from radical treatment and defining the optimal therapeutic approach and sequence. Accurate diagnóstico of oligometastatic disease offers the possibility of administering ablative treatments such as Stereotactic Body Radiation Therapy (SBRT) or surgery, which could improve the prognosis of these patients. On the other hand, oligoprogression is a more recent concept that describes progression in a few sites in patients with globally controlled metastatic disease. Ablative treatment with SBRT allows for continued systemic treatment in these selected patients and results in greater long-term disease control and survival in multiple studies of patients with oligometastatic breast cancer. This approach represents a paradigm shift in the integration of these ablative techniques with systemic therapies, with the aim of improving the prognosis and quality of life of patients. The integration of new systemic agents with SBRT also generates debate about the optimal sequence of treatment and is therefore another topic of discussion.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 ","pages":"Article 100501"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46282170","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Cáncer neuroendocrino de mama, presentación de un caso y técnicas diagnósticas 神经内分泌乳腺癌，病例介绍及诊断技术

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100514

María Isabel Merlos-Martínez , Francisco Martínez-Díaz , Alejandro Huelbes-Ros

引用次数: 0

Distribución de los genotipos de los polimorfismos RS4244285 y RS12248560 del gen CYP2C19 asociados con la sobrevivencia al cáncer de mama en las mujeres CYP2C19基因rs4244285和rs12248560多态性与女性乳腺癌生存相关的基因型分布

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100535

Ángel Roco-Videla , Raúl Aguilera-Eguía , Mariela Olguin-Barraza

引用次数: 0

Controversias y retos en la radioterapia del cáncer de mama 乳腺癌放射治疗的争议和挑战

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100498

Manuel Algara

引用次数: 0

Calidad de vida y satisfacción posterior a cirugía oncoplástica unilateral. Experiencia de un hospital oncológico de Latinoamérica 单侧肿瘤整形术后的生活质量和满意度。拉丁美洲肿瘤医院的经验

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100548

Marcelo Chávez Díaz, José Tapia Amaya, Danilo Díaz Aybar, María del Rosario Cueva Pérez

{"title":"Calidad de vida y satisfacción posterior a cirugía oncoplástica unilateral. Experiencia de un hospital oncológico de Latinoamérica","authors":"Marcelo Chávez Díaz, José Tapia Amaya, Danilo Díaz Aybar, María del Rosario Cueva Pérez","doi":"10.1016/j.senol.2023.100548","DOIUrl":"https://doi.org/10.1016/j.senol.2023.100548","url":null,"abstract":"<div><h3>Introduction</h3><p>Oncoplastic surgery (COP) has had a great development, allowing safe oncological resections, preventing potential deformities and asymmetries. We evaluated the impact on quality of life in patients with COP level I and II, using the BREAST Q BCT questionnaire and the desire for symmetrization after adjuvant therapy.</p></div><div><h3>Methodology</h3><p>50 patients diagnosed with breast cancer, treated with unilateral COP (Level I and Level II), were studied during the period between October 2017 and May 2022, to whom the BREAST Q BCT postoperative questionnaire was applied, in addition to survey on the desire for symmetrization.</p></div><div><h3>Results</h3><p>In the domains of the BREAST Q studied, they recorded: \"psychosocial well-being\" (median of 83), \"sexual well-being\" (median of 66), \"physical well-being\" (median of 76), \"satisfaction with the operated breast\" (median of 80), \"satisfaction with the information received\" (median of 76) and \"satisfaction with the health team\" (median of 100). No statistical relationship was found between the variables studied and the median scores of the \"satisfaction of operated breast\" domain. Only 10% of the patients expressed the desire for symmetrization.</p></div><div><h3>Conclusion</h3><p>The results show high levels of satisfaction in COP level I and II unilateral, having an impact on the quality of life of the patients; expressing the desire for symmetrization, predominant in level II mammoplasties and extreme COP.</p></div>","PeriodicalId":38058,"journal":{"name":"Revista de Senologia y Patologia Mamaria","volume":"36 4","pages":"Article 100548"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49789959","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Can breast cancer be reirradiated? 乳腺癌可以再放射吗?

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100497

María Beatriz Pinar Sedeño , Ana Calín Lorca , Laura García Cabrera

引用次数: 0

Importancia del diagnóstico diferencial de los tumores fibroepiteliales mamarios en adolescentes. Descripción de un caso 青少年乳腺纤维上皮肿瘤的鉴别诊断意义。案例描述

Revista de Senologia y Patologia Mamaria Pub Date : 2023-10-01 DOI: 10.1016/j.senol.2023.100489

Abrahan Jesús Barrios Evies , Johnny Alexander Padrón Sanabria , Mariaisabel Oriana Cedeño Miranda , Ángel Fernando Betancourt Sosa

引用次数: 0